On October 14, during the MATWIN board meeting, Mablink’s COO Valérie Attuil was pitching in front of a panel of investors as part of the 2nd Oncology Upward Investment event.
Mablink’s ADC platform, along with 2 other startups, was awarded by this jury of 15 of the most influential European investors, among 10 pre-selected startups.
The jury was composed of representatives from Advent France Biotechnology, Aglaia Oncology Funds, Angels Santé, Auriga Partners, Bpifrance, Fondation Fournier-Majoie, Go Capital, i2020 Accelerator, Jeito Capital, Kurma Partners, LSP, OMNES Capital, Seventure and Sofinnova Partners.
Mablink would like to especially thank Lucia Robert, CEO of MATWIN, for her support alongside the process of selection and preparation ahead of the event.